Utilizing A Single Session Problem-Solving Intervention With Caregivers of Pediatric Patients Receiving Chronic Transfusion to Treat Sickle Cell Disease

Completed · Not applicable

Conditions studied: Sickle Cell Disease

In brief

This study seeks to utilize an innovative approach of a single session problem-solving intervention to address psychosocial factors affecting patient outcomes within the pediatric sickle cell population. The study will be a randomized control trial of a single session problem-solving intervention. This original research will investigate the feasibility and efficacy of utilizing a single-session problem-solving intervention to address problems affecting children and families receiving chronic blood transfusions for sickle cell disease in order to: 1) contribute to literature related to single session problem solving interventions with the chronic transfusion sickle cell population and 2) identify a model of sustainable care that reduces the burden of a multiple session intervention and increases access to services. Additionally, this research aims to provide relatively low burden and potentially highly effective intervention into regular care for this population in order to evaluate the feasibility of integrating a single-session problem solving intervention into routine clinical flow, thereby addressing needs more systematically that have been identified by families. Further, this research aims to identify potential utility of medical providers being trained on providing the intervention, which could be part of a future study.

Key facts

Study ID

NCT04606160

Run by

University of Texas Southwestern Medical Center

People needed

20

Starts

2020-12-09

Expected to finish

2022-02-01

Last updated by the study team

2022-03-21

Who can join

Age: 7 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• English speaking
• Patient and/or caregiver of patient between the ages of 7 years to less than 19 at time of enrollment
• Patient and/or caregiver of patient diagnosis of sickle cell disease with sickle cell - SS genotype
• Patient and/or caregiver of patient who has received chronic blood transfusions for at least 6 months and continuing through the duration of the study
• Caregiver and patient pair agree to both participate in the study

You may not qualify if…

• Patient or caregiver of patient who are temporarily on blood transfusions for a transient complication (e.g., priapism or recurrent acute chest syndrome)
• Patient and/or caregiver of patient displaying clinically evident cognitive delay (e.g., stroke with severe cognitive deficits, intellectual disability) that would preclude completion of measures or participation in intervention as defined by the medical team, researcher, or psychologist.
• Patient and/or caregiver of patient who is a ward of state

Where it is running

• Children's Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.